The global compounding pharmacy market size is calculated at USD 18.02 billion in 2025 and is forecasted to reach around USD 31.77 billion by 2034, accelerating at a CAGR of 6.50% from 2025 to 2034. The North America market size surpassed USD 7.28 billion in 2024 and is expanding at a CAGR of 6.49% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Compounding Pharmacy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Compounding Pharmacy Market, by Therapeutic Area
8.1.1. Pain Management
8.1.1.1. Market Revenue and Forecast
8.1.2. Hormone Replacement
8.1.2.1. Market Revenue and Forecast
8.1.3. Dermal Disorders
8.1.3.1. Market Revenue and Forecast
8.1.4. Nutritional Supplements
8.1.4.1. Market Revenue and Forecast
8.1.5. Others
8.1.5.1. Market Revenue and Forecast
9.1. Compounding Pharmacy Market, by Route of Administration
9.1.1. Oral
9.1.1.1. Market Revenue and Forecast
9.1.2. Topical
9.1.2.1. Market Revenue and Forecast
9.1.3. Parenteral
9.1.3.1. Market Revenue and Forecast
9.1.4. Others
9.1.4.1. Market Revenue and Forecast
10.1. Compounding Pharmacy Market, by Application
10.1.1. Pediatric
10.1.1.1. Market Revenue and Forecast
10.1.2. Geriatric
10.1.2.1. Market Revenue and Forecast
10.1.3. Adult
10.1.3.1. Market Revenue and Forecast
10.1.4. Veterinary
10.1.4.1. Market Revenue and Forecast
11.1. Compounding Pharmacy Market, by Compounding Type
11.1.1. Pharmaceutical Dosage Alteration (PDA)
11.1.1.1. Market Revenue and Forecast
11.1.2. Pharmaceutical Ingredient Alteration (PIA)
11.1.2.1. Market Revenue and Forecast
11.1.3. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
11.1.3.1. Market Revenue and Forecast
11.1.4. Others
11.1.4.1. Market Revenue and Forecast
12.1. Compounding Pharmacy Market, by Sterility
12.1.1. Sterile
12.1.1.1. Market Revenue and Forecast
12.1.2. Non-sterile
12.1.2.1. Market Revenue and Forecast
13.1. Compounding Pharmacy Market, by Distribution Channel
13.1.1. Compounding Pharmacy
13.1.1.1. Market Revenue and Forecast
13.1.2. Hospital Pharmacy
13.1.2.1. Market Revenue and Forecast
13.1.3. Others
13.1.3.1. Market Revenue and Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Therapeutic Area
14.1.2. Market Revenue and Forecast, by Route of Administration
14.1.3. Market Revenue and Forecast, by Application
14.1.4. Market Revenue and Forecast, by Compounding Type
14.1.5. Market Revenue and Forecast, by Sterility
14.1.6. Market Revenue and Forecast, by Distribution Channel
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Therapeutic Area
14.1.7.2. Market Revenue and Forecast, by Route of Administration
14.1.7.3. Market Revenue and Forecast, by Application
14.1.7.4. Market Revenue and Forecast, by Compounding Type
14.1.8. Market Revenue and Forecast, by Sterility
14.1.8.1. Market Revenue and Forecast, by Distribution Channel
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Therapeutic Area
14.1.9.2. Market Revenue and Forecast, by Route of Administration
14.1.9.3. Market Revenue and Forecast, by Application
14.1.9.4. Market Revenue and Forecast, by Compounding Type
14.1.10. Market Revenue and Forecast, by Sterility
14.1.11. Market Revenue and Forecast, by Distribution Channel
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Therapeutic Area
14.2.2. Market Revenue and Forecast, by Route of Administration
14.2.3. Market Revenue and Forecast, by Application
14.2.4. Market Revenue and Forecast, by Compounding Type
14.2.5. Market Revenue and Forecast, by Sterility
14.2.6. Market Revenue and Forecast, by Distribution Channel
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Therapeutic Area
14.2.8.2. Market Revenue and Forecast, by Route of Administration
14.2.8.3. Market Revenue and Forecast, by Application
14.2.9. Market Revenue and Forecast, by Compounding Type
14.2.10. Market Revenue and Forecast, by Sterility
14.2.10.1. Market Revenue and Forecast, by Distribution Channel
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Therapeutic Area
14.2.11.2. Market Revenue and Forecast, by Route of Administration
14.2.11.3. Market Revenue and Forecast, by Application
14.2.12. Market Revenue and Forecast, by Compounding Type
14.2.13. Market Revenue and Forecast, by Sterility
14.2.14. Market Revenue and Forecast, by Distribution Channel
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Therapeutic Area
14.2.15.2. Market Revenue and Forecast, by Route of Administration
14.2.15.3. Market Revenue and Forecast, by Application
14.2.15.4. Market Revenue and Forecast, by Compounding Type
14.2.16. Market Revenue and Forecast, by Sterility
14.2.16.1. Market Revenue and Forecast, by Distribution Channel
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Therapeutic Area
14.2.17.2. Market Revenue and Forecast, by Route of Administration
14.2.17.3. Market Revenue and Forecast, by Application
14.2.17.4. Market Revenue and Forecast, by Compounding Type
14.2.18. Market Revenue and Forecast, by Sterility
14.2.18.1. Market Revenue and Forecast, by Distribution Channel
14.3. APAC
14.3.1. Market Revenue and Forecast, by Therapeutic Area
14.3.2. Market Revenue and Forecast, by Route of Administration
14.3.3. Market Revenue and Forecast, by Application
14.3.4. Market Revenue and Forecast, by Compounding Type
14.3.5. Market Revenue and Forecast, by Sterility
14.3.6. Market Revenue and Forecast, by Distribution Channel
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Therapeutic Area
14.3.7.2. Market Revenue and Forecast, by Route of Administration
14.3.7.3. Market Revenue and Forecast, by Application
14.3.7.4. Market Revenue and Forecast, by Compounding Type
14.3.8. Market Revenue and Forecast, by Sterility
14.3.9. Market Revenue and Forecast, by Distribution Channel
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Therapeutic Area
14.3.10.2. Market Revenue and Forecast, by Route of Administration
14.3.10.3. Market Revenue and Forecast, by Application
14.3.10.4. Market Revenue and Forecast, by Compounding Type
14.3.11. Market Revenue and Forecast, by Sterility
14.3.11.1. Market Revenue and Forecast, by Distribution Channel
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Therapeutic Area
14.3.12.2. Market Revenue and Forecast, by Route of Administration
14.3.12.3. Market Revenue and Forecast, by Application
14.3.12.4. Market Revenue and Forecast, by Compounding Type
14.3.12.5. Market Revenue and Forecast, by Sterility
14.3.12.6. Market Revenue and Forecast, by Distribution Channel
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Therapeutic Area
14.3.13.2. Market Revenue and Forecast, by Route of Administration
14.3.13.3. Market Revenue and Forecast, by Application
14.3.13.4. Market Revenue and Forecast, by Compounding Type
14.3.13.5. Market Revenue and Forecast, by Sterility
14.3.13.6. Market Revenue and Forecast, by Distribution Channel
14.4. MEA
14.4.1. Market Revenue and Forecast, by Therapeutic Area
14.4.2. Market Revenue and Forecast, by Route of Administration
14.4.3. Market Revenue and Forecast, by Application
14.4.4. Market Revenue and Forecast, by Compounding Type
14.4.5. Market Revenue and Forecast, by Sterility
14.4.6. Market Revenue and Forecast, by Distribution Channel
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Therapeutic Area
14.4.7.2. Market Revenue and Forecast, by Route of Administration
14.4.7.3. Market Revenue and Forecast, by Application
14.4.7.4. Market Revenue and Forecast, by Compounding Type
14.4.8. Market Revenue and Forecast, by Sterility
14.4.9. Market Revenue and Forecast, by Distribution Channel
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Therapeutic Area
14.4.10.2. Market Revenue and Forecast, by Route of Administration
14.4.10.3. Market Revenue and Forecast, by Application
14.4.10.4. Market Revenue and Forecast, by Compounding Type
14.4.11. Market Revenue and Forecast, by Sterility
14.4.12. Market Revenue and Forecast, by Distribution Channel
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Therapeutic Area
14.4.13.2. Market Revenue and Forecast, by Route of Administration
14.4.13.3. Market Revenue and Forecast, by Application
14.4.13.4. Market Revenue and Forecast, by Compounding Type
14.4.13.5. Market Revenue and Forecast, by Sterility
14.4.13.6. Market Revenue and Forecast, by Distribution Channel
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Therapeutic Area
14.4.14.2. Market Revenue and Forecast, by Route of Administration
14.4.14.3. Market Revenue and Forecast, by Application
14.4.14.4. Market Revenue and Forecast, by Compounding Type
14.4.14.5. Market Revenue and Forecast, by Sterility
14.4.14.6. Market Revenue and Forecast, by Distribution Channel
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Therapeutic Area
14.5.2. Market Revenue and Forecast, by Route of Administration
14.5.3. Market Revenue and Forecast, by Application
14.5.4. Market Revenue and Forecast, by Compounding Type
14.5.5. Market Revenue and Forecast, by Sterility
14.5.6. Market Revenue and Forecast, by Distribution Channel
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Therapeutic Area
14.5.7.2. Market Revenue and Forecast, by Route of Administration
14.5.7.3. Market Revenue and Forecast, by Application
14.5.7.4. Market Revenue and Forecast, by Compounding Type
14.5.8. Market Revenue and Forecast, by Sterility
14.5.8.1. Market Revenue and Forecast, by Distribution Channel
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Therapeutic Area
14.5.9.2. Market Revenue and Forecast, by Route of Administration
14.5.9.3. Market Revenue and Forecast, by Application
14.5.9.4. Market Revenue and Forecast, by Compounding Type
14.5.9.5. Market Revenue and Forecast, by Sterility
14.5.9.6. Market Revenue and Forecast, by Distribution Channel
15.1. Fresenius Kabi
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Fagron NV
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. B. Braun Medical Inc.
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Rx3 Compounding Pharmacy
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Clinigen Group PLC
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Dougherty's Pharmacy, Inc.
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Lorraine's Pharmacy
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Wedgewood Pharmacy
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Institutional Pharmacy Solutions
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Mcguff compounding pharmacy services
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample